52 results
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
.
(h) Litigation. There is no action, suit, proceeding or investigation pending or, to the Knowledge of the Company, threatened (including “cease … Adverse Effect; (iv) have not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other
8-K
EX-1.1
phq5k5v7 nhf7vq
15 Sep 22
Other Events
4:02pm
S-3
EX-1.2
j3cz4ilh1pb4ed8 9o
2 Nov 21
Shelf registration
5:21pm
S-3
EX-4.3
emyq4mdgqk5qd5u421k
2 Nov 21
Shelf registration
5:21pm